Artesunate suppresses oxidative and inflammatory processes by activating Nrf2 and ROS‑dependent p38 MAPK and protects against cerebral ischemia‑reperfusion injury

Lu,Hui; Wang,Bincheng; Cui,Ningning; Zhang,Yanchun

doi:10.3892/mmr.2018.8666

Artesunate suppresses oxidative and inflammatory processes by activating Nrf2 and ROS‑dependent p38 MAPK and protects against cerebral ischemia‑reperfusion injury

Authors:
- Hui Lu
- Bincheng Wang
- Ningning Cui
- Yanchun Zhang
View Affiliations

Affiliations: Department of Neurology, Cangzhou Central Hospital, Cangzhou, Hebei 060000, P.R. China, Department of Neurology, Xuan Wu Hospital, Beijing 100053, P.R. China
Published online on: March 1, 2018 https://doi.org/10.3892/mmr.2018.8666
Pages: 6639-6646

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Artesunate is a semi-synthetic derivative of artemisinin that is used in the treatment of patients with malaria. Artesunate has also been reported to exert immune‑regulatory, antitumor, hepatoprotective, anti‑inflammatory and smooth muscle relaxing functions. The present study aimed to investigate the putative protective effects of artesunate against cerebral ischemia/reperfusion injury (CIRI), and to elucidate the molecular mechanisms underlying its effects. A CIRI mouse model was created via middle cerebral artery occlusion for 2 h, followed by 22 h of reperfusion. Mice were treated with 10‑40 mg/kg artesunate. The present results demonstrated that treatment with artesunate significantly reduced the cerebral infarct volume and potentiated the recovery of neurological function in CIRI mice. Oxidative stress and inflammation markers were revealed to be significantly downregulated following treatment with artesunate in CIRI mice. Furthermore, artesunate was demonstrated to activate nuclear factor erythroid 2‑related factor 2 (Nrf2), inhibit caspase‑3 activity, reduce the apoptosis regulator BAX/apoptosis regulator Bcl‑2 expression ratio and suppress the phosphorylation of the mitogen‑activated protein kinase (MAPK) p38 in CIRI mice. In conclusion, the present findings suggested that artesunate may exert protective effects against CIRI through the suppression of oxidative and inflammatory processes, via activating Nrf2 and downregulating ROS‑dependent p38 MAPK in mice.

View Figures

View References

1	Sorond FA, Tan CO, LaRose S, Monk AD, Fichorova R, Ryan S and Lipsitz LA: Deferoxamine, cerebrovascular hemodynamics, and vascular aging: Potential role for hypoxia-inducible transcription factor-1-regulated pathways. Stroke. 46:2576–2583. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kernan WN, Viscoli CM, Furie KL, Young LH, Inzucchi SE, Gorman M, Guarino PD, Lovejoy AM, Peduzzi PN, Conwit R, et al: Pioglitazone after ischemic stroke or transient ischemic attack. N Engl J Med. 374:1321–1331. 2016. View Article : Google Scholar : PubMed/NCBI
3	Huang X, Cheripelli BK, Lloyd SM, Kalladka D, Moreton FC, Siddiqui A, Ford I and Muir KW: Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): A phase 2, randomised, open-label, blinded endpoint study. Lancet Neurol. 14:368–376. 2015. View Article : Google Scholar : PubMed/NCBI
4	Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, Jovin TG, Khatri P, von Kummer R, Sugg RM, et al: Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 45:759–764. 2014. View Article : Google Scholar : PubMed/NCBI
5	Shan J, Sun L, Wang D and Li X: Comparison of the neuroprotective effects and recovery profiles of isoflurane, sevoflurane and desflurane as neurosurgical pre-conditioning on ischemia/reperfusion cerebral injury. Int J Clin Exp Pathol. 8:2001–2009. 2015.PubMed/NCBI
6	Jiang F, Yang J, Zhang L, Li R, Zhuo L, Sun L and Zhao Q: Rosuvastatin reduces ischemia-reperfusion injury in patients with acute coronary syndrome treated with percutaneous coronary intervention. Clin Cardiol. 37:530–535. 2014.PubMed/NCBI
7	Yu Q, Lu Z, Tao L, Yang L, Guo Y, Yang Y, Sun X and Ding Q: ROS-dependent neuroprotective effects of NaHS in ischemia brain injury involves the PARP/AIF pathway. Cell Physiol Biochem. 36:1539–1551. 2015. View Article : Google Scholar : PubMed/NCBI
8	Zhao B, Chen Y, Sun X, Zhou M, Ding J, Zhan JJ and Guo LJ: Phenolic alkaloids from Menispermum dauricum rhizome protect against brain ischemia injury via regulation of GLT-1, EAAC1 and ROS generation. Molecules. 17:2725–2737. 2012. View Article : Google Scholar : PubMed/NCBI
9	Wang PR, Wang JS, Zhang C, Song XF, Tian N and Kong LY: Huang-Lian-Jie-Du-Decotion induced protective autophagy against the injury of cerebral ischemia/reperfusion via MAPK-mTOR signaling pathway. J Ethnopharmacol. 149:270–280. 2013. View Article : Google Scholar : PubMed/NCBI
10	Cheng CY, Lin JG, Tang NY, Kao ST and Hsieh CL: Electroacupuncture at different frequencies (5 Hz and 25 Hz) ameliorates cerebral ischemia-reperfusion injury in rats: Possible involvement of p38 MAPK-mediated anti-apoptotic signaling pathways. BMC Complement Altern Med. 15:2412015. View Article : Google Scholar : PubMed/NCBI
11	Wang S, Liu K, Seneviratne CJ, Li X, Cheung GS, Jin L, Chu CH and Zhang C: Lipoteichoic acid from an Enterococcus faecalis clinical strain promotes TNF-α expression through the NF-κB and p38 MAPK signaling pathways in differentiated THP-1 macrophages. Biomed Rep. 3:697–702. 2015. View Article : Google Scholar : PubMed/NCBI
12	Nito C, Kamada H, Endo H, Niizuma K, Myer DJ and Chan PH: Role of the p38 mitogen-activated protein kinase/cytosolic phospholipase A2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab. 28:1686–1696. 2008. View Article : Google Scholar : PubMed/NCBI
13	Jie P, Hong Z, Tian Y, Li Y, Lin L, Zhou L, Du Y and Chen L and Chen L: Activation of transient receptor potential vanilloid 4 induces apoptosis in hippocampus through downregulating PI3K/Akt and upregulating p38 MAPK signaling pathways. Cell Death Dis. 6:e17752015. View Article : Google Scholar : PubMed/NCBI
14	Cheng R, Li C, Li C, Wei L, Li L, Zhang Y, Yao Y, Gu X, Cai W, Yang Z, et al: The artemisinin derivative artesunate inhibits corneal neovascularization by inducing ROS-dependent apoptosis in vascular endothelial cells. Invest Ophthalmol Vis Sci. 54:3400–3409. 2013. View Article : Google Scholar : PubMed/NCBI
15	Thanaketpaisarn O, Waiwut P, Sakurai H and Saiki I: Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways. Int J Oncol. 39:279–285. 2011.PubMed/NCBI
16	Cao TH, Jin SG, Fei DS, Kang K, Jiang L, Lian ZY, Pan SH, Zhao MR and Zhao MY: Artesunate protects against sepsis-induced lung injury via heme oxygenase-1 modulation. Inflammation. 39:651–662. 2016. View Article : Google Scholar : PubMed/NCBI
17	Ng DS, Liao W, Tan WS, Chan TK, Loh XY and Wong WS: Anti-malarial drug artesunate protects against cigarette smoke-induced lung injury in mice. Phytomedicine. 21:1638–1644. 2014. View Article : Google Scholar : PubMed/NCBI
18	Wu F, Li J, Guo N, Wang XH and Liao YQ: MiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathway. Am J Cancer Res. 7:405–416. 2017.PubMed/NCBI
19	Svensson LG, Blackstone EH, Apperson-Hansen C, Ruggieri PM, Ainkaran P, Naugle RI, Lima B, Roselli EE, Cooper M, Somogyi D, et al: Implications from neurologic assessment of brain protection for total arch replacement from a randomized trial. J Thorac Cardiovasc Surg. 150:1140–1147.e11. 2015. View Article : Google Scholar : PubMed/NCBI
20	Yuan Y, Yao YF, Hu SN, Gao J and Zhang LL: MiR-133a is functionally involved in doxorubicin-resistance in breast cancer cells MCF-7 via its regulation of the expression of uncoupling protein 2. PLoS One. 10:e01298432015. View Article : Google Scholar : PubMed/NCBI
21	Fernandez-Twinn DS, Blackmore HL, Siggens L, Giussani DA, Cross CM, Foo R and Ozanne SE: The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology. 153:5961–5971. 2012. View Article : Google Scholar : PubMed/NCBI
22	Jones KM, Bhattacharjee R, Krishnamurthi R, Blanton S, Theadom A, Barker-Collo S, Thrift A, Parmar P, Maujean A, Ranta A, et al: Methodology of the stroke self-management rehabilitation trial: An international, multisite pilot trial. J Stroke Cerebrovasc Dis. 24:297–303. 2015. View Article : Google Scholar : PubMed/NCBI
23	Saad MA, Abdelsalam RM, Kenawy SA and Attia AS: Ischemic preconditioning and postconditioning alleviates hippocampal tissue damage through abrogation of apoptosis modulated by oxidative stress and inflammation during transient global cerebral ischemia-reperfusion in rats. Chem Biol Interact. 232:21–29. 2015. View Article : Google Scholar : PubMed/NCBI
24	Shen MH, Zhang CB, Zhang JH and Li PF: Electroacupuncture attenuates cerebral ischemia and reperfusion injury in middle cerebral artery occlusion of rat via modulation of apoptosis, inflammation, oxidative stress, and excitotoxicity. Evid Based Complement Alternat Med. 2016:94386502016. View Article : Google Scholar : PubMed/NCBI
25	Sosunov SA, Ameer X, Niatsetskaya ZV, Utkina-Sosunova I, Ratner VI and Ten VS: Isoflurane anesthesia initiated at the onset of reperfusion attenuates oxidative and hypoxic-ischemic brain injury. PLoS One. 10:e01204562015. View Article : Google Scholar : PubMed/NCBI
26	Buch P, Patel V, Ranpariya V, Sheth N and Parmar S: Neuroprotective activityof Cymbopogon martinii against cerebral ischemia/reperfusion-induced oxidative stress in rats. J Ethnopharmacol. 142:35–40. 2012. View Article : Google Scholar : PubMed/NCBI
27	Palencia G, Medrano JÁ, Ortiz-Plata A, Farfán DJ, Sotelo J, Sánchez A and Trejo-Solís C: Anti-apoptotic, anti-oxidant, and anti-inflammatory effects of thalidomide on cerebral ischemia/reperfusion injury in rats. J Neurol Sci. 351:78–87. 2015. View Article : Google Scholar : PubMed/NCBI
28	Zhang M, Su L, Xiao Z and Liu X and Liu X: Methyl jasmonate induces apoptosis and pro-apoptotic autophagy via the ROS pathway in human non-small cell lung cancer. Am J Cancer Res. 6:187–199. 2016.PubMed/NCBI
29	Zhou L, Chen L, Wang J and Deng Y: Astragalus polysaccharide improves cardiac function in doxorubicin-induced cardiomyopathy through ROS-p38 signaling. Int J Clin Exp Med. 8:21839–21848. 2015.PubMed/NCBI
30	Yong Y, Matthew S, Wittwer J, Medrano JÁ, Ortiz-Plata A, Farfán DJ, Sotelo J, Sánchez A and Trejo-Solís C: Dichamanetin inhibits cancer cell growth by affecting ROS-related signaling components through mitochondrial-mediated apoptosis. Anticancer Res. 33:5349–5355. 2013.PubMed/NCBI
31	Lin H, Gao X, Chen G, Sun J, Chu J, Jing K, Li P, Zeng R and Wei B: Indole-3-carbinol as inhibitors of glucocorticoid-induced apoptosis in osteoblastic cells through blocking ROS-mediated Nrf2 pathway. Biochem Biophys Res Commun. 460:422–427. 2015. View Article : Google Scholar : PubMed/NCBI
32	Lucas IK and Kolodziej H: Trans-resveratrol induces apoptosis through ROS-triggered mitochondria-dependent pathways in A549 human lung adenocarcinoma epithelial cells. Planta Med. 81:1038–1044. 2015. View Article : Google Scholar : PubMed/NCBI
33	Jiang M, Li J, Peng Q, Sun J, Chu J, Jing K, Li P, Zeng R and Wei B: Neuroprotective effects of bilobalide on cerebral ischemia and reperfusion injury are associated with inhibition of pro-inflammatory mediator production and down-regulation of JNK1/2 and p38 MAPK activation. J Neuroinflammation. 11:1672014. View Article : Google Scholar : PubMed/NCBI
34	Qi SH, Hao LY, Yue J, Zong YY and Zhang GY: Exogenous nitric oxide negatively regulates the S-nitrosylation p38 mitogen-activated protein kinase activation during cerebral ischaemia and reperfusion. Neuropathol Appl Neurobiol. 39:284–297. 2013. View Article : Google Scholar : PubMed/NCBI